The liver X receptor agonist LXR 623 restricts flavivirus replication.


Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 25 6 2021
medline: 25 2 2023
entrez: 24 6 2021
Statut: ppublish

Résumé

The vector-borne flaviviruses (VBFVs) are well known for causing great misery and death in humans worldwide. The VBFVs include those transmitted by mosquitos, such as Zika virus (ZIKV), dengue virus; and those transmitted by ticks including the tick-borne flavivirus serocomplex and Powassan virus (POWV). Two of our recent reports showed that intracranial POWV infection in the reservoir host,

Identifiants

pubmed: 34162308
doi: 10.1080/22221751.2021.1947749
pmc: PMC8259867
doi:

Substances chimiques

2-(2-chloro-4-fluorobenzyl)-3-(4-fluorophenyl)-7-(trifluoromethyl)-2H-indazole 0
Antiviral Agents 0
Cytokines 0
Indazoles 0
Liver X Receptors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1378-1389

Références

J Infect Dis. 2018 May 25;217(12):1942-1951
pubmed: 29518228
Antimicrob Agents Chemother. 2019 Aug 23;63(9):
pubmed: 31307983
Cancer Res. 2004 Nov 1;64(21):7686-9
pubmed: 15520170
Cell. 1998 May 29;93(5):693-704
pubmed: 9630215
Antiviral Res. 2003 Jan;57(1-2):129-46
pubmed: 12615309
Curr Opin Virol. 2014 Dec;9:134-42
pubmed: 25462445
Infect Ecol Epidemiol. 2013 Aug 30;3:
pubmed: 24003364
FEBS Lett. 2017 Oct;591(19):2978-2991
pubmed: 28555747
J Biol Chem. 2007 Nov 2;282(44):31882-90
pubmed: 17766241
Cell Rep. 2016 Sep 6;16(10):2576-2592
pubmed: 27568284
J Virol. 2005 Oct;79(20):12828-39
pubmed: 16188985
FASEB J. 2016 Jul;30(7):2570-9
pubmed: 27025962
Circ Res. 2011 Apr 15;108(8):996-1001
pubmed: 21493922
Eur Heart J. 2012 Jan;33(2):264-73
pubmed: 21606082
PLoS One. 2018 Jul 25;13(7):e0200358
pubmed: 30044847
Virology. 2017 Jun;506:130-140
pubmed: 28388487
N Engl J Med. 2016 Mar 10;374(10):951-8
pubmed: 26862926
Cell Host Microbe. 2007 Oct 11;2(4):229-39
pubmed: 18005741
J Immunol. 2013 Jun 15;190(12):6520-32
pubmed: 23686490
Sci Rep. 2016 May 06;6:25481
pubmed: 27149934
Viruses. 2011 Feb;3(2):160-71
pubmed: 22049308
Nat Commun. 2018 Jan 9;9(1):106
pubmed: 29317641
J Virol. 2016 Sep 29;90(20):9058-74
pubmed: 27489280
Curr Opin Neurol. 2017 Oct;30(5):500-507
pubmed: 28617719
J Virol Methods. 1996 Jan;56(1):67-75
pubmed: 8690769
PLoS One. 2012;7(10):e47912
pubmed: 23112871
Biochim Biophys Acta. 2011 Aug;1812(8):982-94
pubmed: 21193033
Cell Host Microbe. 2016 May 11;19(5):720-30
pubmed: 27066744
Cell Host Microbe. 2016 Oct 12;20(4):423-428
pubmed: 27693308
J Neurovirol. 2018 Feb;24(1):75-87
pubmed: 29147886
Virology. 2009 Jun 20;389(1-2):8-19
pubmed: 19419745
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
Cell Rep. 2016 Jun 14;15(11):2315-22
pubmed: 27268504
Pharmacol Res. 2014 Oct;88:3-11
pubmed: 24657242
J Clin Invest. 2006 Mar;116(3):607-14
pubmed: 16511593
Prog Lipid Res. 2016 Oct;64:123-137
pubmed: 27702593
Sci Rep. 2016 Dec 23;6:39775
pubmed: 28008958
Cell Microbiol. 2018 Aug;20(8):e12884
pubmed: 29933527
Nat Rev Microbiol. 2018 Feb 12;16(3):125-142
pubmed: 29430005
Sci Rep. 2018 Sep 28;8(1):14543
pubmed: 30266962
Antimicrob Agents Chemother. 2015 Oct 26;60(1):307-15
pubmed: 26503654
Cell Stem Cell. 2016 Aug 4;19(2):258-265
pubmed: 27162029
Exp Cell Biol. 1986;54(5-6):287-300
pubmed: 3026862
Virology. 2017 Jan 15;501:54-62
pubmed: 27863275
Intervirology. 2011;54(4):202-16
pubmed: 21293097
Front Cell Infect Microbiol. 2018 Nov 02;8:388
pubmed: 30450339
J Virol. 2004 Mar;78(6):2701-10
pubmed: 14990690
PLoS Negl Trop Dis. 2017 Jan 31;11(1):e0005346
pubmed: 28141800
PLoS One. 2014 Feb 21;9(2):e87412
pubmed: 24586275
Vector Borne Zoonotic Dis. 2017 Jul;17(7):453-462
pubmed: 28498740
Cell Host Microbe. 2018 Jun 13;23(6):819-831.e5
pubmed: 29902443
Cancer Res. 1978 Nov;38(11 Pt 1):3751-7
pubmed: 29704
J Virol. 2016 Jan 06;90(7):3342-54
pubmed: 26739055
Emerg Microbes Infect. 2017 Aug 23;6(8):e77
pubmed: 28831192
Annu Rev Immunol. 2018 Apr 26;36:279-308
pubmed: 29345964
Antiviral Res. 2015 Dec;124:110-21
pubmed: 26526588
Front Microbiol. 2017 Nov 28;8:2286
pubmed: 29234310
Semin Diagn Pathol. 2019 May;36(3):170-176
pubmed: 31006554
PLoS Pathog. 2018 May 10;14(5):e1006952
pubmed: 29746606

Auteurs

Luwanika Mlera (L)

Biology of Vector-Borne Viruses Section, Laboratory of Virology, NIAID/NIH, Hamilton, MT, USA.

Danielle K Offerdahl (DK)

Biology of Vector-Borne Viruses Section, Laboratory of Virology, NIAID/NIH, Hamilton, MT, USA.

David W Dorward (DW)

Microscopy Unit, Research Technologies Branch, NIAID/NIH, Hamilton, MT, USA.

Aaron Carmody (A)

Research Technologies Branch, NIAID/NIH, Hamilton, MT, USA.

Abhilash I Chiramel (AI)

Innate Immunity and Pathogenesis Section, Laboratory of Virology, NIAID/NIH, Hamilton, MT, USA.

Sonja M Best (SM)

Innate Immunity and Pathogenesis Section, Laboratory of Virology, NIAID/NIH, Hamilton, MT, USA.

Marshall E Bloom (ME)

Biology of Vector-Borne Viruses Section, Laboratory of Virology, NIAID/NIH, Hamilton, MT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH